Management of Gastrointestinal Toxicities From Ixazomib: Tips to Curb Nausea, Vomiting, Diarrhea, and Constipation
An oncology pharmacist discusses how to manage GI toxicities in multiple myeloma patients.
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis
Here we review current prognostic models, risk factors, and prophylaxis methods to provide a practical approach to preventing CNS relapse in patients with DLBCL.